Title : Upregulation of interleukin-13 and its receptor in a murine model of bleomycin-induced scleroderma.

Pub. Date : 2004 Dec

PMID : 15564778






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Upregulation of interleukin-13 and its receptor in a murine model of bleomycin-induced scleroderma. Bleomycin interleukin 13 Mus musculus
2 RESULTS: RT-PCR showed that both IL-4 and IL-13 mRNA levels in skin lesions were increased and peaked after 4 weeks of bleomycin treatment. Bleomycin interleukin 13 Mus musculus
3 In skin lesions, IL-13 receptor (IL-13R) alpha2 expression was augmented mainly in the infiltrating mononuclear cells after 4 weeks of bleomycin exposure. Bleomycin interleukin 13 Mus musculus
4 CONCLUSION: These data demonstrate that in skin lesions levels of IL-13 as well as its receptor increase in parallel with DSc progression, suggesting that IL-13 promotes the progression of cutaneous fibrosis/sclerosis in the murine model of bleomycin-induced scleroderma. Bleomycin interleukin 13 Mus musculus
5 CONCLUSION: These data demonstrate that in skin lesions levels of IL-13 as well as its receptor increase in parallel with DSc progression, suggesting that IL-13 promotes the progression of cutaneous fibrosis/sclerosis in the murine model of bleomycin-induced scleroderma. Bleomycin interleukin 13 Mus musculus